Snapshot: September Highlights

A selection of articles you may have missed from September 2023, including a breakdown of big pharma revenues versus headcount, a look at a drug that has taken nearly 40 years to reach the market, and an interview with a CMO of a company looking to create an entirely new diagnostic modality.